Funder: Cancer Research Institute

Due Dates: December 1, 2025: Initial Protocol Concept submission deadline | April 10, 2026: Invited Full Proposal submission deadline

Funding Amounts: Up to $1,000,000 per trial; indirect costs up to 10% in addition to the award; milestone-based payments.

Summary: Supports investigator-initiated clinical trials in immunotherapy to advance innovative cancer treatments and mechanistic understanding.

Key Information: Open to academic PIs worldwide at non-profit institutions; no citizenship restrictions.